State Of Wisconsin Investment Board Prometheus Biosciences, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$103.46 - $126.29 $917,172 - $1.12 Million	8,865 Added 70.37%	21,463 $2.3 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $37,899 - $123,187	1,051 Added 9.1%	12,598 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$28.17 - $59.01 $14,085 - $29,505	-500 Reduced 4.15%	11,547 $681,000
Q2 2022 Aug 15, 2022	SELL	$22.39 - $38.94 $614,672 - $1.07 Million	-27,453 Reduced 69.5%	12,047 $340,000
Q4 2021 Feb 11, 2022	BUY	$22.28 - $39.54 $552,544 - $980,592	24,800 Added 168.71%	39,500 $1.56 Million
Q2 2021 Aug 12, 2021	BUY	$16.8 - $29.65 $246,960 - $435,855	14,700 New	14,700 $361,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.